ERJ Open Research (Oct 2020)

Phenotypic characterisation of early COPD: a prospective case–control study

  • Borja G. Cosío,
  • Sergi Pascual-Guardia,
  • Alicia Borras-Santos,
  • Germán Peces-Barba,
  • Salud Santos,
  • Laura Vigil,
  • Juan José Soler-Cataluña,
  • Cristina Martínez-González,
  • Ciro Casanova,
  • Pedro J. Marcos,
  • Carlos J. Alvarez,
  • José Luis López-Campos,
  • Joaquim Gea,
  • Judith Garcia-Aymerich,
  • Jesús Molina,
  • Miguel Román,
  • Jorge Moises,
  • Viktoria Szabo,
  • Elizabeth A. Reagan,
  • Raúl San José Estépar,
  • George Washko,
  • Alvar Agustí,
  • Rosa Faner,
  • Full list of field participating investigators in the study:,
  • Borja G. Cosio,
  • Rocío Cordova Diaz,
  • María Magdalena Pan Naranjo,
  • Joan Palmer Sancho,
  • Miguel Román Rodríguez,
  • Alvar Agustí,
  • Rosa Faner Canet,
  • Joan Albert Barberà,
  • Josep Roca Torrent,
  • Yolanda Torralba Garcia,
  • Jorge Moises Lafuente,
  • Anna Maria Pedro Pijoan,
  • Amparo Hervas Docón,
  • Carmen Herranz,
  • Núria Sanchez Ruano,
  • Joaquim Gea,
  • Diego A ChiaradíaRodríguez,
  • Anna Rodó-Pin,
  • Clara Martín-Ontiyuelo,
  • Mireia Admetlló,
  • Concepción Ballano Castro,
  • Laura Gutiérrez Martín,
  • JoséIgnacio Aoiz Linares,
  • Sergi Pascual-Guardia,
  • Marta Mourelo Cereijo,
  • Germán Peces-Barba Romero,
  • José Fernández Arias,
  • Carolina Gotera Rivera,
  • Manuel Martin Bernal,
  • Guillermo Gallardo Madueño,
  • Andrés Alcázar Peral,
  • Carmelo Palacios Miras,
  • Maria Teresa Pinedo Moraleda,
  • Maria Belén Torres Labandeira,
  • Mercedes Colomo Rodríguez,
  • María Concepción Rodríguez Gallego,
  • Carmen Lobon Agundez,
  • Mónica Nácher Conches,
  • María José Mansilla,
  • Rosario Serrano Martín,
  • Carlos J. Álvarez Martínez,
  • Marta Padilla Bernáldez,
  • Jesús Molina París,
  • Laura Vigil Giménez,
  • Eduard Monsó Molas,
  • Laia Seto Gort,
  • Mañas Montserrat Baré,
  • Anna Maria Fabra Noguera,
  • JoséLuís López Campos,
  • Carmen Calero Acuña,
  • Laura Carrasco Hernández,
  • Salud Santos Perez,
  • Montserrat Navarro,
  • Elisabeth Serra,
  • Ferran Ferrer Keysers,
  • Damaris Batallé,
  • M Dolores Peleato Catalan,
  • Albert Dorca,
  • Javier Burgos,
  • Juan José,
  • Soler-Cataluña Noelia González García,
  • Lourdes Sánchez Sánchez,
  • Cristina Martínez González,
  • Amador Prieto Fernández,
  • Susana Martínez González,
  • Ciro Casanova Macario,
  • Delia Mayato,
  • Pedro J Marcos Rodriguez,
  • Luis Domínguez Juncal,
  • Rosario Timiraos Carrasco,
  • Rosa Garcia Palenzuela

DOI
https://doi.org/10.1183/23120541.00047-2020
Journal volume & issue
Vol. 6, no. 4

Abstract

Read online

The phenotypic characteristics of chronic obstructive pulmonary disease (COPD) in individuals younger than 50 years of age (early COPD) are not well defined. This prospective, multicentre, case–control study sought to describe these characteristics and compare them with those of smokers (≥10 pack-years) of similar age with normal spirometry (controls). We studied 92 cases (post-bronchodilator forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) <0.7) and 197 controls. Results were contrasted with participants with similar inclusion criteria recruited into the ECLIPSE and COPDGene cohorts. Cases had moderate airflow limitation (FEV1 71.3±20.8%) but were often symptomatic, used healthcare resources frequently, had air trapping (residual volume 150.6±55.5% ref.), had reduced diffusing capacity (84.2±20.7% ref.) and had frequent evidence of computed tomography (CT) emphysema (61%). Of note, less than half of cases (46%) had been previously diagnosed with COPD. Interestingly, they also often reported a family history of respiratory diseases and had been hospitalised because of respiratory problems before the age of 5 years more frequently than controls (12% versus 3%, p=0.009). By and large, these observations were reproduced when available in the ECLIPSE and COPDGene cohorts. These results show that early COPD is associated with substantial health impact and significant structural and functional abnormalities, albeit it is often not diagnosed (hence, treated). The fact that a sizeable proportion of patients with early COPD report a family history of respiratory diseases and/or early-life events (including hospitalisations before the age of 5 years) renders further support to the possibility of early-life origin of COPD.